InvestorsHub Logo
Followers 0
Posts 5
Boards Moderated 0
Alias Born 10/26/2020

Re: None

Monday, 10/26/2020 2:48:12 PM

Monday, October 26, 2020 2:48:12 PM

Post# of 4876
BY MT Newswires — 1:58 PM ET 10/26/2020
BioSig Technologies (BSGM) tumbled almost 40% after saying its ViralClear subsidiary was ending phase II testing of a combination of its merimepodib enzyme inhibitor and Gilead Science's (GILD) remdesivir anti-viral in adult patients with advanced COVID-19. The move follows a safety monitoring committee observing an imbalance in survival rates making unlikely the trial would meet its primary safety endpoints.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent GILD News